About Immunis
Immunis is a private company based in Irvine, California. It has reported $32,364,963 raised in two offerings on Form D since July 2024.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 28, 2026 | Jun 15, 2026 | $11,975,000fully sold | 12 | $997K | Options, Simple Agreement for Future EquityRule 506(b) | Form D ↗ |
| Jun 17, 2024 | Jul 1, 2024amended Oct 24, 2024 | $20,389,963of $25.0M target | 27 | $755K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Total, two offerings | $32,364,963 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Immunis's Form D filed Jun 15, 2026.
